Fig 9 - by Farshid Maleki (20521649)

Subjects:

Fig 6 - by Farshid Maleki (20521649)

Subjects:

Fig 7 - by Farshid Maleki (20521649)

Subjects:

Fig 8 - by Farshid Maleki (20521649)

Subjects:

Decoding the Structure–Property–Function Relationships in Covalent Organic Frameworks for Sustainable Battery Design by Tarek M. Madkour (4921354)

Subjects:

Basic statistics (medians and quartiles) of distances and auxiliary angles on the left and right sides and results of significance tests (Wilcoxon test). by Wojciech Derkowski (13449914)

Deletion of <i>Trgal11</i> resulted in a significant decrease in the transcription of cellobiohydrolase and endoglucanase but not β-glucosidase genes. by Fanglin Zheng (4844064)

IRI group exhibited a significantly greater decrease in proportion of gambles accepted compared to the IRI group in the second block. by Yasuhiro Mochizuki (3308349)

Cell proliferation was significantly decreased in full-length HPV16 E1 (pEGFP-E1) transfected cells. by Fern Baedyananda (11888703)

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Dynorphin Neuropeptides Decrease Apparent Proton Affinity of ASIC1a by Occluding the Acidic Pocket by Lilia Leisle (11356934)

“…Prolonged acidosis, as it occurs during ischemic stroke, induces neuronal death via acid-sensing ion channel 1a (ASIC1a). Concomitantly, it desensitizes ASIC1a, highlighting the pathophysiological significance of modulators of ASIC1a acid sensitivity. …”

Dynorphin Neuropeptides Decrease Apparent Proton Affinity of ASIC1a by Occluding the Acidic Pocket by Lilia Leisle (11356934)

“…Prolonged acidosis, as it occurs during ischemic stroke, induces neuronal death via acid-sensing ion channel 1a (ASIC1a). Concomitantly, it desensitizes ASIC1a, highlighting the pathophysiological significance of modulators of ASIC1a acid sensitivity. …”

S2 File - by Phuong Nguyen Thi Thu (11503489)

Subjects:

Clinical and demographic characteristics of the patients (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Data at baseline and after 12 weeks of treatment with DAA therapy (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Metabolic, renal, and hematological changes after 12 weeks of direct-acting antiviral treatment (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Relationship between changes in clinical laboratory r and hepatitis C viral genotypes (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Comparison of anemia incidence before and after 12 weeks of treatment with DAAs in the study population and among HCV genotypes (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Flowchart of the study. by Phuong Nguyen Thi Thu (11503489)

Subjects:

Multiple logistic regression analysis showing the factors associated with anemia in patients with HCV infection after 12 weeks of DAA therapy (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects: